Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES

Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES

Alimentary Pharmacology & TherapeuticsEarly View (Online Version of Record published before inclusion in an issue) Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV... Monday HCV News Ticker- Hepatitis C: Coffee, Medicare,...

Close